- PAT software to optimize biopharmaceutical development and manufacturing processes
- Chemometrics software for Design of Experiments (DoE) and multivariate data analysis (MVA)
Malmö, Sweden, January 8, 2013– Umetrics announces that they have entered into a global sales partnership with Sartorius Stedim Biotech (SSB), a leading international pharmaceutical and biotech supplier. Under the cooperation agreement SSB will embed Umetrics technology into SSB products. SSB will assume global marketing and distribution of the Umetrics portfolio of Chemometrics software for the pharmaceutical and biopharmaceutical industries. SSB will also integrate Umetrics software programs as private label products into its own bioprocess portfolio and market these as stand-alone solutions under both brands under a dual branding arrangement.
The major areas of application for these software systems are critical process steps, such as cell culture processes or specific purification steps in the biopharmaceutical industry. Umetrics is a highly specialized, leading provider of chemometrics software worldwide for modeling and optimizing biopharmaceutical development and manufacturing processes. Multivariate data analysis (MVA) enables all process parameters to be added in batch trajectories, among other things, so that process variations and their causes can be displayed transparently in real time. DoE software (Design of Experiments) permits these critical process parameters to be efficiently identified and quantified and development cycles to be considerably shortened.
Lars Lindstrom GM of Umetrics said “Umetrics stands to benefit from the global sales structures of SSB. Thanks to SSB’s international reach and solid market standing in the biopharma sector, we can gain access to substantially more customers. SSB’s integrated solutions with embeded Umetrics MVA & DoE technology will clearly create added value for SSB and our customers. I anticipate that this will considerably boost the biopharmaceutical industry’s interest in and usage of Umetrics’ products”.
About Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of “turning science into solutions.” Headquartered in Aubagne, France, Sartorius Stedim Biotech is listed on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany. The company employs approx. 2,850 people, and in 2011 earned sales revenue of 477.3 million euros.. www.sartorius.com
About Umetrics
Umetrics is a world leader in multivariate technology, providing software for design of experiments (DOE) and multivariate data analysis (MVDA). Umetrics offers complete solutions for both off-line and online data analysis (continuous and batch processes), all supported by training and consulting services. Umetrics is a subsidiary of MKS Instruments, Inc. (NASDAQ: MKSI), a worldwide provider of monitoring and control technologies.
More information can be found at Umetrics web page www.umetrics.com.
Contact:
Amos Dor
Phone: +1 (408) 750.2907
[email protected]